EQS-News: CRS initiates new chapter by appointing leading industry expert Elisabeth Lackner as Chief Executive Officer
Mannheim, Germany, March 15, 2024 – CRS Clinical Research Services, an expert early-phase Contract Research Organization (CRO), today announced the appointment of Dr. Elisabeth Lackner as Chief Executive Officer (CEO), effective today.
- Mannheim, Germany, March 15, 2024 – CRS Clinical Research Services, an expert early-phase Contract Research Organization (CRO), today announced the appointment of Dr. Elisabeth Lackner as Chief Executive Officer (CEO), effective today.
- Dr. Elisabeth Lackner, CEO of CRS, commented: “I am honoured to join this great management team and to guide the organization into its next chapter of strategic growth and innovation.
- “Together, we aim to propel CRS to new heights, centred on internationalization, strategic expansion, and a relentless pursuit of excellence."
- Dr. Lackner is a highly experienced and well-respected global thought leader with over 20 years of experience in the healthcare industry.